Data / Crowdfunding / Colorado / Canine Life Sciences Inc.
Canine Life Sciences Inc.: crowdfunding raise on NetCapital Funding Portal Inc., $10,000 to $477,539 (2021)
Canine Life Sciences Inc., a corporation in Denver, CO, filed a Form C with the SEC on November 19, 2021 to raise $10,000 to $477,539 in common stock through NetCapital Funding Portal Inc.. The offering closed on March 8, 2022. In its most recent fiscal year it reported $49,391 in revenue and a net loss of $449,310, with 5 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.caninebiologics.com
- Funding portal
- NetCapital Funding Portal Inc.
- Address
- 2145 S CLERMONT ST SUITE 3, Denver, CO 80222
- Legal form
- Corporation
- Jurisdiction
- CO
- Incorporated
- December 23, 2019
- SEC CIK
- 0001857342
Offering terms
From the amendment filed November 19, 2021.
- Security
- Common Stock
- Price
- $0.81
- Target
- $10,000
- Maximum
- $477,539
- Deadline
- March 8, 2022
- Portal compensation
- Up to 4.9% of amount raised for a successful offering and a listing fee of up to $5,000
Financials
From the Form C-AR filed March 21, 2022.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $49,391 | $5,823 | sec.gov |
| Cost of goods sold | $72,559 | $5,650 | sec.gov |
| Net income | $-449,310 | $-353,517 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $159,970 | $404,133 | sec.gov |
| Cash | $24,684 | $98,886 | sec.gov |
| Accounts receivable | $11,110 | $25,894 | sec.gov |
| Short-term debt | $66,000 | $19,100 | sec.gov |
| Long-term debt | $0 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| March 21, 2022 | Annual report | Not listed | Not listed | sec.gov | ||
| March 17, 2022 | Progress update | $10,000 | $477,539 | March 8, 2022 | End of offering. Issuer closed its offering with estimated gross proceeds of $39,141. The foregoing is in regard only to the amount raised under the Section 4(a)(6) exemption. | sec.gov |
| November 19, 2021 | Amendment | $10,000 | $477,539 | March 8, 2022 | the issuer is extending the offering deadline. | sec.gov |
| October 1, 2021 | Amendment | $10,000 | $477,539 | December 9, 2021 | updated verbiage in the solutions section of the offering page. | sec.gov |
| September 24, 2021 | Amendment | $10,000 | $477,539 | December 9, 2021 | the issuer extended the offering date. | sec.gov |
| September 10, 2021 | Amendment | $10,000 | $477,539 | December 9, 2021 | the issuer extended the offering date. | sec.gov |
| September 9, 2021 | Offering | $10,000 | $477,539 | November 9, 2021 | sec.gov | |
| May 5, 2021 | Offering | $50,000 | $1,070,000 | April 30, 2022 | sec.gov |
Updated March 21, 2022. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.